The effects of treatment on delayed cutaneous hypersensitivity responses (DNCB, croton oil, and recall antigen) in patients with genitourinary cancer.
D000941:Antigens / Q000008:administration & dosage; D003436:Croton Oil / Q000276:immunology; D004137:Dinitrochlorobenzene / Q000276:immunology; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed; D007680:Kidney Neoplasms / Q000276:immunology; D008297:Male; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000276:immunology; D012867:Skin / Q000276:immunology*; D001749:Urinary Bladder Neoplasms / Q000276:immunology; D014565:Urogenital Neoplasms / Q000276:immunology* / Q000628:therapy
D000941:Antigens; D004137:Dinitrochlorobenzene; D003436:Croton Oil